Inventaire - your friends and communities are your best library

Diagnosis and treatment of acute promyelocytic leukemia.

author

Peter G Maslak

published in: Current Oncology Reports

date of publication: 2007-09-01

main subject: leukemia

Cites articles 47

Date

Title

Authors

2007-03-01

Using quantification of the PML-RARalpha transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia

Ramón García-Sanz, Marcos González Díaz
2007-01-04

Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention

Mar Tormo, Dolors Colomer, Miguel A Sanz
2006-05-25

Molecular response in acute promyelocytic leukemia: a direct comparison of regular and real-time RT-PCR
2006-03-20

In vivo analysis of the role of aberrant histone deacetylase recruitment and RAR alpha blockade in the pathogenesis of acute promyelocytic leukemia

Hiromichi Matsushita, Pier Paolo Scaglioni, Eduardo Magalhães Rego, Pier Paolo Pandolfi, Hayato Miyachi, Samia M Majid, Mantu Bhaumik
2006-12-20

Is Cytarabine Useful in the Treatment of Acute Promyelocytic Leukemia? Results of a Randomized Trial From the European Acute Promyelocytic Leukemia Group

Stéphane de Botton, Christine Chomienne, Sylvie Chevret, Pierre Fenaux, Hervé Dombret, Lionel Adès, Emmanuel Raffoux, Arnaud Pigneux, Thierry Lamy, Anne Vekhoff, Augustin Ferrant, Agnès Guerci-Bresler, Nathalie Fegueux, Frederic Maloisel
2006-06-01

Single-agent liposomal all-trans retinoic acid can cure some patients with untreated acute promyelocytic leukemia: an update of The University of Texas M. D. Anderson Cancer Center Series.

Hagop Kantarjian, Susan O'Brien, Michael Andreeff, Michael J. Keating, Apostolia Maria Tsimberidou, Elihu Estey, Maribel Tirado-Gomez, Gabriel Lopez-Berestein
2006-01-01

Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

Sylvie Chevret, Miguel A Sanz, Bruno Quesnel, Josep-Maria Ribera, Christine Chomienne, Pierre Fenaux, European APL Group
2005-12-22

Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia

Hagop Kantarjian, Alessandra Ferrajoli, Stefan Faderl, Srdan Verstovsek, Guillermo Garcia-Manero, Elihu Estey
2004-03-24

All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia

Samuel Waxman, Hugues de Thé
2004-11-08

Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group

Sylvie Chevret, Pierre Fenaux
2003-10-23

Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group

Javier de la Serna
2003-01-01

Arsenic trioxide (trisenox) therapy for acute promyelocytic leukemia in the setting of hematopoietic stem cell transplantation

Sergio Giralt
2002-08-15

All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.

Clara D. Bloomfield, Martin S. Tallman, Frederick R. Appelbaum, James H. Feusner, Cheryl L. Willman, Peter H. Wiernik, Charles A Schiffer
2002-06-01

Experience with gemtuzumab ozogamycin ("mylotarg") and all-trans retinoic acid in untreated acute promyelocytic leukemia

Hagop Kantarjian, Susan O'Brien, Jorge Eduardo Cortes, Elihu Estey, Francis J Giles
2001-09-15

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia
2001-11-01

Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemia
2001-04-01

Antibody therapy for residual disease in acute myelogenous leukemia
2001-02-01

Role of promyelocytic leukemia (PML) protein in tumor suppression

Eduardo Magalhães Rego
2000-08-29

Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins
2000-08-01

A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements
2000-08-15

Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups
2000-03

CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy
2000-08-01

Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies"
1999-04-01

Annexin II and bleeding in acute promyelocytic leukemia

Gabriela Cesarman-Maus
1999-09-01

The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia
1999-08-15

A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group

Laurent Degos, Eric Solary, Pierre Fenaux, Claude Preudhomme, Christine Chomienne
1998-11-01

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide
1997-08-01

Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion gene
1997-09

Fusion of retinoic acid receptor alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia

Suzanne Kamel-Reid
1997-05-01

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells

Samuel Waxman
1997-05-01

A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression
1997-05-01

Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study

Clara D. Bloomfield

Article - wd:Q36913223

Welcome to Inventaire

the library of your friends and communities

learn more